SCPHARMACEUTICALS INC(NASDAQ:SCPH) stock News

SCPH Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Halper Sadeh LLC - Mentions: ZIMV ARIS

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZIMV, ARIS, SCPH on Behalf of Shareholders

a month ago - By: Kahn Swick & Foti, LLC

SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH

2 months ago - By: The Motley Fool

SCPH Revenue Up 99%

2 months ago - By: Benzinga - Mentions: GSAT PGY ADV REAL ...

Earnings Scheduled For August 7, 2025

2 months ago - By: Halper Sadeh LLC - Mentions: IMXI HBI VTLE

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMXI, HBI, VTLE, SCPH on Behalf of Shareholders

2 months ago - By: Brodsky & Smith LLC - Mentions: VTLE IMXI HBI MNKD ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: scPharmaceuticals Inc. (Nasdaq – SCPH), Vital Energy, Inc. (NYSE – VTLE), International Money Express, Inc. (Nasdaq - IMXI), HanesBrands Financial Corp. (NYSE - HBI)

2 months ago - By: Kahn Swick & Foti, LLC

SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH

2 months ago - By: Halper Sadeh LLC - Mentions: VTLE

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTLE and SCPH on Behalf of Shareholders

2 months ago - By: Stocktwits - Mentions: MNKD

MannKind’s $360M scPharma Deal Splits Analysts — Retail Traders Call It ‘Bizarro Territory’ But Stay Bullish

5 months ago - By: Benzinga

Insights Ahead: scPharmaceuticals's Quarterly Earnings

2 months ago - By: Halper Sadeh LLC

SCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of scPharmaceuticals Inc. Is Fair to Shareholders

2 months ago - By: Ademi & Fruchter LLP

Shareholder Alert: The Ademi Firm Investigates Whether scPharmaceuticals Inc. Is Obtaining a Fair Price for Its Public Shareholders

2 months ago - By: Stocktwits - Mentions: MNKD

MannKind Corporation to Acquire scPharmaceuticals: More Details Inside

2 months ago - By: MannKind - Mentions: MNKD

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

2 months ago - By: scPharmaceuticals Inc.

scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111

2 months ago - By: Zacks Investment Research - Mentions: CUE

scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates

2 months ago - By: scPharmaceuticals Inc.

scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

2 months ago - By: Zacks Investment Research - Mentions: CTKB

Cytek Biosciences, Inc. (CTKB) Beats Q2 Earnings Estimates

3 months ago - By: scPharmaceuticals Inc.

scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025

5 months ago - By: Yahoo Finance - Mentions: UNH APP KKR VEEV

Prominent Investor Is a Fan of UnitedHealth Group’s (UNH) New CEO

5 months ago - By: Zacks Investment Research - Mentions: FBIO

ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates

5 months ago - By: scPharmaceuticals Inc.

scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

5 months ago - By: Zacks Investment Research - Mentions: INSM

Insmed (INSM) Reports Q1 Loss, Tops Revenue Estimates

5 months ago - By: scPharmaceuticals Inc.

scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025

6 months ago - By: scPharmaceuticals Inc.

SCPHARMACEUTICALS INC (SCPH) Stock News

SCPH Latest News, Press Relases and Analysis

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZIMV, ARIS, SCPH on Behalf of Shareholders

SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH

SCPH Revenue Up 99%

Earnings Scheduled For August 7, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMXI, HBI, VTLE, SCPH on Behalf of Shareholders

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: scPharmaceuticals Inc. (Nasdaq – SCPH), Vital Energy, Inc. (NYSE – VTLE), International Money Express, Inc. (Nasdaq - IMXI), HanesBrands Financial Corp. (NYSE - HBI)

SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTLE and SCPH on Behalf of Shareholders

MannKind’s $360M scPharma Deal Splits Analysts — Retail Traders Call It ‘Bizarro Territory’ But Stay Bullish

Insights Ahead: scPharmaceuticals's Quarterly Earnings

SCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of scPharmaceuticals Inc. Is Fair to Shareholders

Shareholder Alert: The Ademi Firm Investigates Whether scPharmaceuticals Inc. Is Obtaining a Fair Price for Its Public Shareholders

MannKind Corporation to Acquire scPharmaceuticals: More Details Inside

MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases

scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111

scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates

scPharmaceuticals Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

Cytek Biosciences, Inc. (CTKB) Beats Q2 Earnings Estimates

scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025

Prominent Investor Is a Fan of UnitedHealth Group’s (UNH) New CEO

ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates

scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

Insmed (INSM) Reports Q1 Loss, Tops Revenue Estimates

scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025

scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences